Abstract:Purpose: Cancer diagnosis involves a multi-step process. Accurate identification of the tumor, staging and development of cancer cells is crucial for selecting optimal treatments to minimize disease recurrence. Quantum dots (QDs) represent an exciting class of fluorescent nanoprobes in molecular detection and targeted tumor imaging. Materials and methods: In this study, graphene quantum dots (GQDs) were synthesized by pyrolysis of citric acid (CA) as a carbon precursor under high temperatures. The morphology of the obtained GQDs was first characterized using physical (TEM and DLS) and spectroscopic (fluorescence, FTIR and UV-Vis) methods. In the following,99mTc-labeled GQDs were prepared in the presence of SnCl2.2H2O as a reducing agent between 95 and 100 °C. The biodistribution and tumor targeting efficiency of radiolabeled GQDs as a novel agent for C6 glioma tumor scintigraphy in an animal model were evaluated. Furthermore, organ uptake, human serum albumin binding and tumor accumulation were measured. Results: The TEM image of the prepared GQDs showed a relatively uniform size distribution in the range of diameter 6-9 nm and spherical shape. Radiolabeled GQDs showed a radiochemical yield of >97% (n = 3). Through incubation in human serum, almost 15% of 99mTc-labeled GQDs degraded after 6 h. The amount of uptake in xenograft models of glioma C6 rats was 1.10 ± 0.36% of injection dose per gram after 1 h. The kidneys, intestinal and glioma tumor sites were observed via scintigraphy imaging. Conclusion: Our data suggest that 99mTc-labeled GQDs, as a new radiotracer, efficiently accumulate in the tumor site and could be included as a radiotracer for detecting glioma tumors.

Aptamer-Conjugated Dendrimer-Modified Quantum Dots For Glioblastoma Cells Imaging

Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging

Quantum dot-labeled aptamer nanoprobes specifically targeting glioma cells.

Arginine-Glycine-Aspartic Acid-Conjugated Dendrimer-Modified Quantum Dots For Targeting And Imaging Melanoma

Biomimetic semiconducting polymer dots for highly specific NIR-II fluorescence imaging of glioma

Amphiphilic Graphene Quantum Dots As Self‐Targeted Fluorescence Probes for Cell Nucleus Imaging

Cetuximab-conjugated Iodine Doped Carbon Dots As a Dual Fluorescent/ct Probe for Targeted Imaging of Lung Cancer Cells.

Dye-cored polylysine dendrimer as luminescent nanoplatform for imaging-guided anticancer drug delivery

Au:Cdhgte Quantum Dots for in Vivo Tumor-Targeted Multispectral Fluorescence Imaging

Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells.

Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids

Technetium-99m radiolabeling of graphene quantum dots (GQDs) as a new probe for glioblastoma tumor imaging

Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use

Targeting Cancer Cells with Biotin–dendrimer Conjugates

Motif‐Designed Peptide Nanofibers Decorated with Graphene Quantum Dots for Simultaneous Targeting and Imaging of Tumor Cells

Biomimetic Nanocomposites Cloaked with Bioorthogonally Labeled Glioblastoma Cell Membrane for Targeted Multimodal Imaging of Brain Tumors

Ag2S quantum dot-based magnetic resonance/fluorescence dual-mode imaging nanoprobes for tumor diagnosis

Synthesis, characterization, and pharmacological evaluation of dextrin capped cadmium sulfide quantum dots conjugated with temozolomide for drug delivery and imaging application

<SUP>68</SUP>Ga-labeled dendrimer-entrapped gold nanoparticles for PET/CT dual-modality imaging and immunotherapy of tumors

Direct Solvent-Derived Polymer-Coated Nitrogen-Doped Carbon Nanodots with High Water Solubility for Targeted Fluorescence Imaging of Glioma.

Technetium‐99m Radiolabeled Nucleolin-Targeted Aptamer for Glioma Tumor Imaging in Murine Models